Matinas Biopharma (MTNB) Return on Assets (ROA) (2013 - 2026)
Matinas Biopharma (MTNB) Return on Assets (ROA) from Dec 31, 2013 to Mar 31, 2026. The TTM Matinas Biopharma (MTNB) Return on Assets (ROA) is -32.70%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROA
Quarterly ROA
Annual Return on Assets (ROA) change of Matinas Biopharma (MTNB)
| Year | Return on Assets (ROA) | Change |
|---|---|---|
| 2025 | -143.41% | -25.25% |
| 2024 | -191.85% | +109.92% |
| 2023 | -91.39% | +95.06% |
| 2022 | -46.85% | +23.43% |
| 2021 | -37.96% | N/A |
| 2021 | -37.96% | +20.00% |
| 2020 | -31.63% | N/A |
| 2020 | -31.63% | -100.00% |
| 2019 | -Infinity% | +Infinity% |
| 2018 | -70.61% | -34.27% |
| 2017 | -107.42% | +38.80% |
| 2016 | -77.39% | -28.79% |
| 2015 | -108.68% | -64.27% |
| 2014 | -304.17% | +828.90% |
| 2013 | -32.74% | N/A |